Global Retirement Partners’s Insight Molecular Diagnostics IMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMDX
AIC
Global Retirement Partners's IMDX Position: Q3 2026 in Review
Global Retirement Partners sold out of Insight Molecular Diagnostics (IMDX) in Q3 2026, closing a stake of 1 share — an estimated $6 sold.
Global Retirement Partners first reported a position in IMDX in Q2 2025 and held it in 4 quarters. The position peaked at $8 in Q4 2025. 44 funds tracked by Wall St. Rank hold IMDX as of Q3 2026.
- Global Retirement Partners reported no remaining Insight Molecular Diagnostics position as of Q3 2026 after selling out during the quarter.
- Global Retirement Partners sold 1 Insight Molecular Diagnostics share in Q3 2026, an estimated $6.
- Global Retirement Partners first reported a position in Insight Molecular Diagnostics in Q2 2025 and held it in 4 quarters.
- Global Retirement Partners's Insight Molecular Diagnostics position peaked at $8 in Q4 2025.
- 44 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2026.
Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.